Fulgent Genetics, Inc. (FLGT) Cash Flow Statement
Fulgent Genetics, Inc. (FLGT) generated -$83.7M of operating cash flow over the twelve months to 2026-06-30, spent $20.1M on capital expenditure and had free cash flow of -$103.8M, according to EquiReason's reading of its SEC filings.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
FLGTFulgent Genetics, Inc.Follow FLGT — free
—
Price chart with a free account
- Market cap
- 553.1M
- P/E TTM
- —
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 5 Nov, in 12 days
| Line | FY2016 Dec 16 | FY2017 Dec 17 | FY2018 Dec 18 | FY2019 Dec 19 | FY2020 Dec 20 | FY2021 Dec 21 | FY2022 Dec 22 | FY2023 Dec 23 | FY2024 Dec 24 | FY2025 Dec 25 | TTM Jun 26 | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 0.00 | 0.00 | -0.00 | 0.01 | 0.14 | 0.54 | 0.25 | 0.03 | 0.02 | -0.10 | -0.08 | |
| Capital expenditure | 0.00 | 0.00 | 0.00 | 0.00 | 0.04 | 0.02 | 0.02 | 0.02 | 0.04 | 0.02 | -0.02 | |
| Free cash flow | 0.00 | -0.00 | -0.00 | 0.00 | 0.11 | 0.51 | 0.23 | 0.00 | -0.02 | -0.12 | -0.10 | |
| Share repurchases | — | — | — | 0.00 | 0.00 | — | 0.07 | 0.03 | 0.00 | 0.01 | — | |
| Stock-based compensation | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 | 0.02 | 0.03 | 0.04 | 0.04 | 0.04 | — |
USD billions · SEC XBRL
Fulgent Genetics, Inc. — questions
- What is Fulgent Genetics, Inc.'s operating cash flow?
- -$83.7M over the twelve months to 2026-06-30.
- How much does Fulgent Genetics, Inc. spend on capital expenditure?
- $20.1M over the twelve months to 2026-06-30.
- What is Fulgent Genetics, Inc.'s free cash flow?
- -$103.8M over the twelve months to 2026-06-30: operating cash flow minus capital expenditure.
Every figure on this page comes from Fulgent Genetics, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.